Evidence map›Paper›PMID 40108551›Full record

ArticleBMC public health2025

Multidisciplinary lifestyle treatment for type 2 diabetes in 12 European countries: protocol for a quasi-experimental study.

Isabel Diez-Valcarce, Marta M Pisano-González, Cristina Fernández García, Jaana Linstrom, Jelka Zaletel, Claudia Giacomozzi, Foetini Tolika, Inés Rey Hidalgo, Alberto Lana

Abstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Isabel Diez-ValcarceRegional Health Service of the Principality of Asturias (SESPA), Plaza del Carbayon 1,2, Oviedo, Asturias, 33017, España.ORCID https://orcid.org/0000-0003-2476-7356
Marta M Pisano-GonzálezMinistry of Health of the Principality of Asturias (CSPA), Calle Ciriaco Miguel Vigil, 9, Oviedo, 33005, España. MARTAMARIA.PISANOGONZALEZ@asturias.org.ORCID https://orcid.org/0000-0002-6485-9370
Cristina Fernández GarcíaRegional Health Service of the Principality of Asturias (SESPA), Plaza del Carbayon 1,2, Oviedo, Asturias, 33017, España.ORCID https://orcid.org/0000-0001-5403-4431
Jaana LinstromDepartment of Public Health, National Institute for Health and Welfare, POB 30, Helsinki, 00271, Finland.ORCID https://orcid.org/0000-0001-9255-020X
Jelka ZaletelNational Institute of Public Health, Trubarjeva cesta 2, Ljubljana, 1000, Slovenia.ORCID https://orcid.org/0000-0002-2884-9669
Claudia GiacomozziDepartment of Cardiovascular and Endocrine-Metabolic Diseases and Aging, The Italian National Institute of Health, Viale Regina Elena 299, 00161, Rome, Italy.ORCID https://orcid.org/0000-0001-6950-4934
Foetini TolikaDirectorate of Public Health, 1st Regional Healthcare Authority of Attica, Ministry of Health, 18, Valaoritou Str., Athens, 10671, Greece.
Inés Rey HidalgoHealth Research Institute of the Principality of Asturias (ISPA), Avda. del Hospital Universitario, Oviedo, s/n, 33011, España.ORCID https://orcid.org/0000-0002-7270-4555
Alberto LanaHealth Research Institute of the Principality of Asturias (ISPA), Avda. del Hospital Universitario, Oviedo, s/n, 33011, España.ORCID https://orcid.org/0000-0003-0500-8805

Funding

European Commission 101082427
6 · The paper itself

Abstract

backgroundThe incidence and prevalence of type 2 diabetes (T2DM) are expected to continue rising. T2DM causes life-threatening, disabling and costly complications, and significantly reduces quality of life and life expectancy. The burden of T2DM can be reduced using comprehensive lifestyle modifications. The aim of this study is to evaluate the applicability and cost-effectiveness of a multicomponent, multidisciplinary lifestyle program in 22 European regions and to generate guidelines for transfer to European health care systems.

methodsA quasi-experimental study (without a control group) will be conducted to evaluate the CARE4DIABETES program, which is based on the Reverse Diabetes 2Now best practice. The program will involve more than 120 healthcare professionals and 860 people with T2DM from 12 European countries - Belgium, Bulgaria, Finland, Hungary, Italy, Greece, Malta, Poland, Portugal, Slovakia, Slovenia and Spain. Patients will be enrolled based on clinical criteria and motivation for change. The program will have two phases, an intensive phase (6 months) with face-to-face and online training to achieve behavioral change, and an online aftercare phase (6 months) to consolidate changes. The program will be evaluated for impact, sustainability and cost-effectiveness using a combination of validated questionnaires at baseline, six months and one year after the start of the intervention. CLINICAL TRIAL NUMBER: Trial registration number: ISRCTN62063346.

Indexed as

Diabetes Mellitus, Type 2Life StyleCost-Benefit AnalysisEuropeFemaleHumansMaleMulticenter Studies as TopicProgram EvaluationDiabetes mellitusHealthy lifestyleSecondary preventionSelfcareType 2. health education

Identifiers

PMID40108551
PMCPMC11924863

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.